Checkpoint Therapeutics, Inc.
CKPT · NASDAQ
3/31/2025 | 12/31/2024 | 9/30/2024 | 6/30/2024 | |
|---|---|---|---|---|
| Market Cap | $2,417 | $126,958 | $96,660 | $74,879 |
| - Cash | $33,042 | $6,604 | $4,703 | $4,951 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | -$30,625 | $120,354 | $91,957 | $69,928 |
| Revenue | $0 | $0 | $0 | $41 |
| % Growth | – | – | -100% | – |
| Gross Profit | $0 | -$16,809 | -$6,366 | -$4,439 |
| % Margin | – | – | – | -10,826.8% |
| EBITDA | -$11,149 | -$28,829 | -$9,724 | -$6,673 |
| % Margin | – | – | – | -16,275.6% |
| Net Income | -$11,212 | -$28,900 | -$9,725 | -$6,670 |
| % Margin | – | – | – | -16,268.3% |
| EPS Diluted | -18.74 | -0.7 | -0.23 | -0.18 |
| % Growth | -2,577.1% | -204.3% | -27.8% | – |
| Operating Cash Flow | -$11,686 | -$7,177 | -$11,210 | -$6,240 |
| Capital Expenditures | $0 | $0 | $0 | $0 |
| Free Cash Flow | -$11,686 | -$7,177 | -$11,210 | -$6,240 |